{"id":82349,"date":"2025-11-16T19:24:39","date_gmt":"2025-11-16T19:24:39","guid":{"rendered":"https:\/\/www.europesays.com\/se\/82349\/"},"modified":"2025-11-16T19:24:39","modified_gmt":"2025-11-16T19:24:39","slug":"purdue-betalar-miljarder-i-uppgorelse-om-opioidkrisen","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/82349\/","title":{"rendered":"Purdue betalar miljarder i uppg\u00f6relse om opioidkrisen"},"content":{"rendered":"<p>Wikipedia (sv)<\/p>\n<p>Purdue Pharma var ett familje\u00e4gt amerikanskt l\u00e4kemedelsf\u00f6retag, som framf\u00f6r allt var k\u00e4nt som tillverkare av opioidl\u00e4kemedlet OxyContin.<br \/>\nPurdue Pharma grundades 1892 i New York av de b\u00e5da l\u00e4karna John Purdue Gray och George Frederick Bingham som Purdue Frederick, f\u00f6rs\u00e4ljare av patentmedicin. F\u00f6retaget s\u00e5lde till exempel patentmedicinen Gray\u2019s Glycerine Tonic, baserad p\u00e5 sherry och marknadsf\u00f6rd som anv\u00e4ndbar mot allehanda sjukdomstillst\u00e5nd.<br \/>\nF\u00f6retaget k\u00f6ptes 1952 av br\u00f6derna Arthur,  Mortimer och Raymond Sackler. Det flyttade till Yonkers i New York och utvecklades s\u00e5 sm\u00e5ningom till ett l\u00e4kemedelsf\u00f6retag. Det, och systerf\u00f6retaget Napp Pharmaceuticals Group i Storbritannien, drevs av de tv\u00e5 yngre br\u00f6derna Mortimer och Raymond Sackler, med Raymond som formell chef f\u00f6r Purdue Pharma.<br \/>\nUnder ett antal \u00e5r, innan det kom in p\u00e5 omr\u00e5det sm\u00e4rtstillande medel, var f\u00f6retaget litet och specialiserat p\u00e5 icke-receptbelagda produkter s\u00e5som medel att ta bort \u00f6ronvax och laxativ. En tidig stors\u00e4ljare var den 1966 f\u00f6rv\u00e4rvade lokalantiseptiska l\u00f6sningen Betadine. Denna k\u00f6ptes in i stora kvantiteter av den amerikanska krigsmakten f\u00f6r att f\u00f6rhindra infektioner f\u00f6r s\u00e5rade soldater under Vietnamkriget.<br \/>\nPurdue Pharma tillverkade sm\u00e4rtstillande medel som hydromorfon, oxikodon, fentanyl, kodein och hydrokodon. Det \u00e4r k\u00e4nt f\u00f6r l\u00e4kemedel som MS Contin, OxyContin och Ryzolt. \u00c5r 1972 lanserades l\u00e4kemedlet Contin. \u00c5r 1984 kom morfindep\u00e5tabletten MS Contin. \u00c5r 1996 lanserades dep\u00e5tabletten OxyContin, som blev ett stors\u00e4ljande l\u00e4kemedel.<br \/>\nDen \u00e4ldsta brodern Arthur Sacklers tidigare \u00e4gda tredjedel av f\u00f6retaget s\u00e5ldes efter hans d\u00f6d 1987 till de tv\u00e5 yngre br\u00f6derna.<br \/>\nF\u00f6retagets huvudkontor ligger numera i Stamford i Connecticut, och forskning bedrivs i Cranbury i New Jersey. Tillverkning sker i Wilson i North Carolina, Totowa i New Jersey och Coventry i Rhode Island.<br \/>\nUtlandsverksamhet bedrivs i det relaterade f\u00f6retaget Mundipharma.<\/p>\n","protected":false},"excerpt":{"rendered":"Wikipedia (sv) Purdue Pharma var ett familje\u00e4gt amerikanskt l\u00e4kemedelsf\u00f6retag, som framf\u00f6r allt var k\u00e4nt som tillverkare av opioidl\u00e4kemedlet&hellip;\n","protected":false},"author":2,"featured_media":82350,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[22,23,26,27,17,21,538,24,25,28,29,15,268,16,7945,18,34,31,33,32,30,19,20,74,51,52,53,54],"class_list":{"0":"post-82349","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-varlden","8":"tag-breaking-news","9":"tag-breakingnews","10":"tag-featured-news","11":"tag-featurednews","12":"tag-headlines","13":"tag-huvudnyheter","14":"tag-lakemedel-medicinteknik","15":"tag-latest-news","16":"tag-latestnews","17":"tag-main-news","18":"tag-mainnews","19":"tag-news","20":"tag-nordamerika","21":"tag-nyheter","22":"tag-oxycontin","23":"tag-rubriker","24":"tag-se","25":"tag-svenska","26":"tag-sverige","27":"tag-sweden","28":"tag-swedish","29":"tag-top-stories","30":"tag-topstories","31":"tag-usa","32":"tag-varlden","33":"tag-world","34":"tag-world-news","35":"tag-worldnews"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115561015796178581","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/82349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=82349"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/82349\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/82350"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=82349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=82349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=82349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}